Unveiling the Impact of Senescent Cells on Aging at the Single-Cell Level

New research reveals how senescent cells influence tissue aging and dysfunction through complex interactions uncovered at the single-cell level in vivo. These findings provide critical insights into the role of cellular senescence in aging and age-related diseases.
A groundbreaking study led by researchers from Kyoto University has introduced an innovative in vivo system to explore how senescent cells influence aging through complex mechanisms within living tissues. Published in Nature Aging, this research provides detailed insights into the behavior of senescent cells and their effects on cellular and tissue functions.
Cellular senescence is a process where cells permanently stop dividing in response to stressors such as DNA damage, oxidative stress, or oncogene activation. While this mechanism plays a crucial role in preventing tumor development and aiding in tissue repair, the accumulation of senescent cells over time has been linked to various age-related diseases and tissue decline.
One of the major challenges in aging research has been understanding the precise roles of senescent cells in vivo due to difficulties in identifying and studying these cells within complex tissue environments. To overcome this, the research team developed two genetically engineered mouse models that can induce senescence by activating key pathways—ERK and p38 MAPK—via inducible expression of constitutively active MEK1 (caMEK1) or MKK6 (caMKK6). These models, combined with a dual-color labeling system, allow scientists to distinguish primary senescent cells from secondary ones based on fluorescence markers, enabling gene expression analysis at the single-cell level.
Using this system, the team observed that inducing senescence in liver and colon tissues resulted in hallmark features such as increased p21 expression, DNA damage response activation, and secretion of SASP factors. Transcriptomic profiling demonstrated that senescent cells exhibit highly diverse gene expression patterns, influenced by tissue type, the method of induction, and spatial arrangement within tissues.
A key discovery was that SASP factors like IL-1β, especially secreted by macrophages, could induce secondary senescence in neighboring cells, emphasizing the importance of intercellular signaling. Additionally, the study found that senescent cells disrupt normal tissue organization, such as liver zonation—an essential aspect for metabolic function—which was notably seen in caMEK1-induced models. This disruption led to decreased expression of metabolic genes, mirroring changes observed in aged tissues.
Importantly, the transcriptomic profiles of the senescent cells closely resembled those found in naturally aged mice and humans, providing evidence for a causal role of senescence in tissue dysfunction associated with aging. By capturing the dynamics of primary and secondary senescence in vivo, this research offers valuable insights into how senescent cells influence tissue health and aging.
The study's findings not only deepen our understanding of aging processes but also establish new avenues for therapeutic interventions targeting senescence. The generated mouse models serve as powerful tools for future research aimed at mitigating age-related decline and developing anti-aging strategies.
For more details, see the publication: Yuko Sogabe et al., "Characterizing primary and secondary senescence in vivo," Nature Aging (2025).
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
U.S. Biosecurity at Risk After Cancellation of mRNA Vaccine Contracts by Trump Administration
The Trump administration's cancellation of key mRNA vaccine contracts weakens U.S. pandemic defenses, raising concerns about future biosecurity risks and preparedness against emerging flu threats.
How Nerve Cells in Fat Tissue Influence Obesity and Metabolic Health
New research uncovers how nerve cells sensing mechanical forces in fat tissue influence obesity and metabolic health, opening new avenues for treatment strategies.
Combination of Ivonescimab and Chemotherapy Enhances Progression-Free Survival in EGFR-Positive NSCLC Patients
A groundbreaking Phase III trial shows that combining ivonescimab with chemotherapy significantly prolongs progression-free survival in patients with EGFR-mutant NSCLC, including those with brain metastases, offering new hope for improved lung cancer treatment.
Potential Benefits and Limitations of CBD for Children with Autism: A Research Overview
Emerging research suggests that cannabidiol (CBD) may help reduce problematic behaviors in children with autism, with ongoing studies aiming to confirm its safety and effectiveness. Learn more about the latest findings.



